Biomedical Engineering Reference
In-Depth Information
31. Davies JR, Hovenberg HW, Linden CJ, Howard R, Richardson PS, Sheehan
JK, et al. Mucins in airway secretions from healthy and chronic bronchitic
subjects. Biochem J 1996; 313(Pt 2):431-439.
32. Thornton DJ, Carlstedt I, Howard M, Devine PL, Price MR, Sheehan JK.
Respiratory mucins: identification of core proteins and glycoforms. Biochem
J 1996; 316(Pt 3):967-975.
33. Hovenberg HW, Davies JR, Herrmann A, Linden CJ, Carlstedt I. MUC5AC,
but not MUC2, is a prominent mucin in respiratory secretions. Glycoconj
J 1996; 13(5):839-847.
34. Wickstrom C, Davies JR, Eriksen GV, Veerman EC, Carlstedt I. MUC5B is a
major gel-forming, oligomeric mucin from human salivary gland, respiratory
tract and endocervix: identification of glycoforms and C-terminal cleavage.
Biochem J 1998; 334(Pt 3):685-693.
35. Sheehan JK, Howard M, Richardson PS, Longwill T, Thornton DJ. Physical
characterization of a low-charge glycoform of the MUC5B mucin comprising
the gel-phase of an asthmatic respiratory mucous plug. Biochem J 1999;
338(Pt 2):507-513.
36. Kirkham S, Sheehan JK, Knight D, Richardson PS, Thornton DJ. Heteroge-
neity of airways mucus: variations in the amounts and glycoforms of the
major oligomeric mucins MUC5AC and MUC5B. Biochem J 2002; 361(Pt 3):
537-546.
37. Basbaum CB, Jany B, Finkbeiner WE. The serous cell. Annu Rev Physiol
1990; 52:97-113.
38. Chen Y, Zhao YH, Di YP, Wu R. Characterization of human mucin 5B gene
expression in airway epithelium and the genomic clone of the amino-terminal
and 5'-flanking region. Am J Respir Cell Mol Biol 2001; 25(5):542-553.
39. Groneberg DA, Eynott PR, Lim S, Oates T, Wu R, Carlstedt I, et al. Expres-
sion of respiratory mucins in fatal status asthmaticus and mild asthma. Histo-
pathology 2002; 40(4):367-373.
40. Groneberg DA, Eynott PR, Oates T, Lim S, Wu R, Carlstedt I, et al. Expres-
sion of MUC5AC and MUC5B mucins in normal and cystic fibrosis lung.
Respir Med 2002; 96(2):81-86.
41. Davies JR, Svitacheva N, Lannefors L, Kornfalt R, Carlstedt I. Identification
of MUC5B, MUC5AC and small amounts of MUC2 mucins in cystic fibrosis
airway secretions. Biochem J 1999; 344(Pt 2):321-330.
42. Wanner A. Clinical aspects of mucociliary transport. Am Rev Respir Dis
1977; 116(1):73-125.
43. McDowell EM, Barrett LA, Harris CC, Trump BF. Abnormal cilia in human
bronchial epithelium. Arch Pathol Lab Med 1976; 100(8):429-436.
44. Wanner A, Salathe M, O'Riordan TG. Mucociliary clearance in the airways.
Am J Respir Crit Care Med 1996; 154(6 Pt 1):1868-1902.
45. Pavia D, Agnew JE, Glassman JM, Sutton PP, Lopez-Vidriero MT, Soyka JP,
et al. Effects of iodopropylidene glycerol on tracheobronchial clearance in
stable, chronic bronchitic patients. Eur J Respir Dis 1985; 67(3):177-184.
46. Moretti M, Lopez-Vidriero MT, Pavia D, Clarke SW. Relationship between
bronchial reversibility and tracheobronchial clearance in patients with chronic
bronchitis. Thorax 1997; 52(2):176-180.
